Literature DB >> 18474201

Vagus nerve stimulation: can it be used in adolescents or children with treatment-resistant depression?

Zheya Jenny Yu1, Ronald A Weller, Kendra Sandidge, Elizabeth B Weller.   

Abstract

Vagus nerve stimulation (VNS) therapy has been approved by the US Food and Drug Administration for treatment-resistant depression in patients 18 years of age and older and for intractable epilepsy. Long-term studies suggest VNS has an antidepressant effect in adults. This paper reviews the available clinical data for VNS therapy. Its potential application for treatment-resistant depression in adolescents and children is also discussed.

Entities:  

Mesh：

Year:  2008        PMID： 18474201     DOI： 10.1007/s11920-008-0021-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  49 in total

1.  Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.

Authors:  D Labar; J Murphy; E Tecoma
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder.

Authors:  B Birmaher; D A Brent; D Kolko; M Baugher; J Bridge; D Holder; S Iyengar; R E Ulloa
Journal:  Arch Gen Psychiatry       Date:  2000-01

Review 3.  Vagal nerve stimulation: overview and implications for anesthesiologists.

Authors:  Kevin W Hatton; J Thomas McLarney; Thomas Pittman; Brenda G Fahy
Journal:  Anesth Analg       Date:  2006-11       Impact factor: 5.108

4.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.

Authors:  D A Brent; D Holder; D Kolko; B Birmaher; M Baugher; C Roth; S Iyengar; B A Johnson
Journal:  Arch Gen Psychiatry       Date:  1997-09

5.  Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood.

Authors:  Tove Hallböök; Johan Lundgren; Karin Stjernqvist; Gösta Blennow; Lars-Göran Strömblad; Ingmar Rosén
Journal:  Seizure       Date:  2005-09-19       Impact factor: 3.184

6.  A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

Authors:  Mark S George; A John Rush; Lauren B Marangell; Harold A Sackeim; Stephen K Brannan; Sonia M Davis; Robert Howland; Mitchel A Kling; Francisco Moreno; Barry Rittberg; David Dunner; Thomas Schwartz; Linda Carpenter; Michael Burke; Philip Ninan; Paul Goodnick
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

Review 7.  New antiepileptic drugs: comparison of key clinical trials.

Authors:  J A Cramer; R Fisher; E Ben-Menachem; J French; R H Mattson
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

8.  Aspiration: a potential complication to vagus nerve stimulation.

Authors:  J Lundgren; O Ekberg; R Olsson
Journal:  Epilepsia       Date:  1998-09       Impact factor: 5.864

9.  Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.

Authors:  Linda L Carpenter; Francisco A Moreno; Mitchel A Kling; George M Anderson; William T Regenold; David M Labiner; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2004-09-15       Impact factor: 13.382

10.  Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures.

Authors:  E Ben-Menachem; A Hamberger; T Hedner; E J Hammond; B M Uthman; J Slater; T Treig; H Stefan; R E Ramsay; J F Wernicke
Journal:  Epilepsy Res       Date:  1995-03       Impact factor: 3.045
View more
  8 in total

Review 1.  From TADS and SOFTADS to TORDIA and beyond: what's new in the treatment of adolescent depression?

Authors:  Zheya Jenny Yu; Christopher J Kratochvil; Ronald A Weller; Mira Mooreville; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

2.  New Somatic Treatments for Child and Adolescent Depression.

Authors:  Kathryn R Cullen; Laura E Padilla; Victoria N Papke; Bonnie Klimes-Dougan
Journal:  Curr Treat Options Psychiatry       Date:  2019-11-12

Review 3.  A review of vagus nerve stimulation as a therapeutic intervention.

Authors:  Rhaya L Johnson; Christopher G Wilson
Journal:  J Inflamm Res       Date:  2018-05-16

Review 4.  Rewiring the Lesioned Brain: Electrical Stimulation for Post-Stroke Motor Restoration.

Authors:  Shi-Chun Bao; Ahsan Khan; Rong Song; Raymond Kai-Yu Tong
Journal:  J Stroke       Date:  2020-01-31       Impact factor: 6.967

Review 5.  Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression.

Authors:  Chun-Hong Liu; Ming-Hao Yang; Guang-Zhong Zhang; Xiao-Xu Wang; Bin Li; Meng Li; Marie Woelfer; Martin Walter; Lihong Wang
Journal:  J Neuroinflammation       Date:  2020-02-12       Impact factor: 8.322

Review 6.  Use of Transcutaneous Auricular Vagus Nerve Stimulation as an Adjuvant Therapy for the Depressive Symptoms of COVID-19: A Literature Review.

Authors:  Zhi-Peng Guo; Peter Sörös; Zhu-Qing Zhang; Ming-Hao Yang; Dan Liao; Chun-Hong Liu
Journal:  Front Psychiatry       Date:  2021-12-15       Impact factor: 4.157

7.  Brain structural thickness and resting state autonomic function in adolescents with major depression.

Authors:  Julian Koenig; Melinda Westlund Schreiner; Bonnie Klimes-Dougan; Benjamin Ubani; Bryon Mueller; Michael Kaess; Kathryn R Cullen
Journal:  Soc Cogn Affect Neurosci       Date:  2018-09-04       Impact factor: 3.436

Review 8.  Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice.

Authors:  Jonathan Y Y Yap; Charlotte Keatch; Elisabeth Lambert; Will Woods; Paul R Stoddart; Tatiana Kameneva
Journal:  Front Neurosci       Date:  2020-04-28       Impact factor: 4.677
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.